Literature DB >> 19536569

Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.

Sebastian Hoefert1, Inge Schmitz, Andrea Tannapfel, Harald Eufinger.   

Abstract

The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model. Bone samples from 35 patients with ONJ were analyzed. Control samples were taken from five patients with osteomyelitis (OM), ten patients with osteoradionecrosis, seven patients with osteoporosis and bisphosphonate medication without signs of ONJ, and six osteoporotic elderly patients. Samples were examined using scanning electron microscopy. In 54% of the bone samples of patients with ONJ, microcracks were seen. Inflammatory and connective tissue reactions within the microcracks were evident in 82% of the cases, indicating that these cracks were not artificial. In contrast, only 29% of samples from patients with oral bisphosphonate medication without ONJ, no sample from patients with OM, none of the osteoradionecrosis group, and only 17% from patients with osteoporosis showed microcracks. Statistically significant differences could be found between the ONJ group and the group after irradiation and the group with OM, respectively. The evidence of microcracks could be a first step in the pathogenesis of bisphosphonate-related ONJ. The accumulation of these microcracks leads to a situation that could be named "non-symptomatic ONJ". Disruptions of the mucosal integrity may then allow bacterial invasion, leading to jawbone infection with exposed bone, fistulas, and pain. This state could be called "symptomatic ONJ". Furthermore, an assumed local immunosuppression as indicated by various studies could explain the severe courses of therapy-resistant ONJ as regularly observed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536569     DOI: 10.1007/s00784-009-0300-6

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  55 in total

1.  Mandibular osteoradionecrosis.

Authors:  William M Mendenhall
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

2.  Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

Authors:  Salvatore L Ruggiero; John Fantasia; Eric Carlson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-07-31

3.  Bone remodeling in response to in vivo fatigue microdamage.

Authors:  D B Burr; R B Martin; M B Schaffler; E L Radin
Journal:  J Biomech       Date:  1985       Impact factor: 2.712

4.  Osteoradionecrosis of the mandible: pathogenesis.

Authors:  J Bras; H K de Jonge; J P van Merkesteyn
Journal:  Am J Otolaryngol       Date:  1990 Jul-Aug       Impact factor: 1.808

5.  Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.

Authors:  Torsten Hansen; Martin Kunkel; Achim Weber; C James Kirkpatrick
Journal:  J Oral Pathol Med       Date:  2006-03       Impact factor: 4.253

Review 6.  [Bisphosphonate-associated osteonecrosis of the jaw].

Authors:  M H Abu-Id; Y Açil; J Gottschalk; T Kreusch
Journal:  Mund Kiefer Gesichtschir       Date:  2006-03

7.  Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro.

Authors:  M F Moreau; C Guillet; P Massin; S Chevalier; H Gascan; M F Baslé; D Chappard
Journal:  Biochem Pharmacol       Date:  2006-11-03       Impact factor: 5.858

Review 8.  Radiotherapy-induced mandibular bone complications.

Authors:  Barbara A Jereczek-Fossa; Roberto Orecchia
Journal:  Cancer Treat Rev       Date:  2002-02       Impact factor: 12.111

9.  Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.

Authors:  J S Day; M Ding; P Bednarz; J C van der Linden; T Mashiba; T Hirano; C C Johnston; D B Burr; I Hvid; D R Sumner; H Weinans
Journal:  J Orthop Res       Date:  2004-05       Impact factor: 3.494

10.  The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins.

Authors:  R E Hewitt; A Lissina; A E Green; E S Slay; D A Price; A K Sewell
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

View more
  36 in total

1.  Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts.

Authors:  Joo-Young Ohe; Yong-Dae Kwon; Hyeon-Woo Lee
Journal:  Clin Oral Investig       Date:  2011-09-22       Impact factor: 3.573

Review 2.  The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.

Authors:  Matthew R Allen
Journal:  Odontology       Date:  2011-01-27       Impact factor: 2.634

3.  Comparison of gene expression between mandibular and iliac bone-derived cells.

Authors:  Jung-Tae Lee; So-Young Choi; Hyung-Lak Kim; Jae-Young Kim; Heon-Jin Lee; Tae-Geon Kwon
Journal:  Clin Oral Investig       Date:  2014-11-05       Impact factor: 3.573

4.  RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?

Authors:  Tim Van den Wyngaert; Kristien Wouters; Manon T Huizing; Jan B Vermorken
Journal:  Support Care Cancer       Date:  2011-01-04       Impact factor: 3.603

Review 5.  Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.

Authors:  Cesar A Migliorati; Joel B Epstein; Elliot Abt; James R Berenson
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

Review 6.  Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015.

Authors:  A Khan; A Morrison; A Cheung; W Hashem; J Compston
Journal:  Osteoporos Int       Date:  2015-10-22       Impact factor: 4.507

7.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

8.  Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap.

Authors:  Juliana Lemound; Andrè Eckardt; Horst Kokemüller; Constantin von See; Pit Jacob Voss; Frank Tavassol; Martin Rücker; Majeed Rana; Nils-Claudius Gellrich
Journal:  Clin Oral Investig       Date:  2011-08-05       Impact factor: 3.573

Review 9.  Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies.

Authors:  Si-Huei Lee; Rai-Chi Chan; Shy-Shin Chang; Yin-Ling Tan; Kai-Hsiang Chang; Matthew C Lee; Huai-En Chang; Chien-Chang Lee
Journal:  Support Care Cancer       Date:  2013-11-08       Impact factor: 3.603

10.  Studying the role of microcracks in the pathophysiology of BRONJ.

Authors:  Matthew R Allen
Journal:  Clin Oral Investig       Date:  2009-08-18       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.